300 related articles for article (PubMed ID: 33106178)
1. RNA editing in cancer impacts mRNA abundance in immune response pathways.
Chan TW; Fu T; Bahn JH; Jun HI; Lee JH; Quinones-Valdez G; Cheng C; Xiao X
Genome Biol; 2020 Oct; 21(1):268. PubMed ID: 33106178
[TBL] [Abstract][Full Text] [Related]
2. Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.
Freund EC; Sapiro AL; Li Q; Linder S; Moresco JJ; Yates JR; Li JB
Cell Rep; 2020 May; 31(7):107656. PubMed ID: 32433965
[TBL] [Abstract][Full Text] [Related]
3. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
4. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
5. Structure-mediated modulation of mRNA abundance by A-to-I editing.
Brümmer A; Yang Y; Chan TW; Xiao X
Nat Commun; 2017 Nov; 8(1):1255. PubMed ID: 29093448
[TBL] [Abstract][Full Text] [Related]
6. Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR).
Solomon O; Oren S; Safran M; Deshet-Unger N; Akiva P; Jacob-Hirsch J; Cesarkas K; Kabesa R; Amariglio N; Unger R; Rechavi G; Eyal E
RNA; 2013 May; 19(5):591-604. PubMed ID: 23474544
[TBL] [Abstract][Full Text] [Related]
7. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
[TBL] [Abstract][Full Text] [Related]
8. A-to-I RNA editing as a tuner of noncoding RNAs in cancer.
Liao Y; Jung SH; Kim T
Cancer Lett; 2020 Dec; 494():88-93. PubMed ID: 32822814
[TBL] [Abstract][Full Text] [Related]
9. Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma.
Sharpnack MF; Chen B; Aran D; Kosti I; Sharpnack DD; Carbone DP; Mallick P; Huang K
EBioMedicine; 2018 Jan; 27():167-175. PubMed ID: 29273356
[TBL] [Abstract][Full Text] [Related]
10. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.
Sagredo EA; Blanco A; Sagredo AI; Pérez P; Sepúlveda-Hermosilla G; Morales F; Müller B; Verdugo R; Marcelain K; Harismendy O; Armisén R
Biol Res; 2018 Oct; 51(1):36. PubMed ID: 30290838
[TBL] [Abstract][Full Text] [Related]
11. ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer.
Cho CJ; Myung SJ; Chang S
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398248
[TBL] [Abstract][Full Text] [Related]
12. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS.
Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA
J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307
[TBL] [Abstract][Full Text] [Related]
13. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.
Stellos K; Gatsiou A; Stamatelopoulos K; Perisic Matic L; John D; Lunella FF; Jaé N; Rossbach O; Amrhein C; Sigala F; Boon RA; Fürtig B; Manavski Y; You X; Uchida S; Keller T; Boeckel JN; Franco-Cereceda A; Maegdefessel L; Chen W; Schwalbe H; Bindereif A; Eriksson P; Hedin U; Zeiher AM; Dimmeler S
Nat Med; 2016 Oct; 22(10):1140-1150. PubMed ID: 27595325
[TBL] [Abstract][Full Text] [Related]
14. Diverse selective regimes shape genetic diversity at ADAR genes and at their coding targets.
Forni D; Mozzi A; Pontremoli C; Vertemara J; Pozzoli U; Biasin M; Bresolin N; Clerici M; Cagliani R; Sironi M
RNA Biol; 2015; 12(2):149-61. PubMed ID: 25826567
[TBL] [Abstract][Full Text] [Related]
15. Using mouse models to unlock the secrets of non-synonymous RNA editing.
Jinnah H; Ulbricht RJ
Methods; 2019 Mar; 156():40-45. PubMed ID: 30827465
[TBL] [Abstract][Full Text] [Related]
16. ADAR-deficiency perturbs the global splicing landscape in mouse tissues.
Kapoor U; Licht K; Amman F; Jakobi T; Martin D; Dieterich C; Jantsch MF
Genome Res; 2020 Aug; 30(8):1107-1118. PubMed ID: 32727871
[TBL] [Abstract][Full Text] [Related]
17. ADAR-mediated RNA editing regulates PVR immune checkpoint in colorectal cancer.
Qian CJ; He YS; Guo T; Tao J; Wei ZY; Zhang JL; Bao C; Chen JH
Biochem Biophys Res Commun; 2024 Feb; 695():149373. PubMed ID: 38176170
[TBL] [Abstract][Full Text] [Related]
18. ADAR regulates RNA editing, transcript stability, and gene expression.
Wang IX; So E; Devlin JL; Zhao Y; Wu M; Cheung VG
Cell Rep; 2013 Nov; 5(3):849-60. PubMed ID: 24183664
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
Wang C; Zou J; Ma X; Wang E; Peng G
Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
[TBL] [Abstract][Full Text] [Related]
20. Zinc Finger RNA-Binding Protein Zn72D Regulates ADAR-Mediated RNA Editing in Neurons.
Sapiro AL; Freund EC; Restrepo L; Qiao HH; Bhate A; Li Q; Ni JQ; Mosca TJ; Li JB
Cell Rep; 2020 May; 31(7):107654. PubMed ID: 32433963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
